EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy

Dariush Haghmorad, Majid Eslami, Niloufar Orooji, Iryna Halabitska, Iryna Kamyshna, Oleksandr Kamyshnyi, Valentyn Oksenych

Frontiers in Bioengineering and Biotechnology · 12.03.2025 · 13

DOI: 10.3389/fbioe.2025.1547025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 12.03.2025. Verfasst von Dariush Haghmorad und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The advent of mRNA vaccines, accelerated by the global response to the COVID-19 pandemic, marks a transformative shift in vaccine technology. In this article, we discuss the development, current applications, and prospects of mRNA vaccines for both the prevention and treatment of infectious diseases and oncology. By leveraging the capacity to encode antigens within host cells directly, mRNA vaccines provide a versatile and scalable platform suitable for addressing a broad spectrum of pathogens and tumor-specific antigens. We highlight recent advancements in mRNA vaccine design, innovative delivery mechanisms, and ongoing clinical trials, with particular emphasis on their efficacy in combating infectious diseases, such as COVID-19, Zika, and influenza, as well as their emerging potential in cancer immunotherapy. We also address critical challenges, including vaccine stability, optimization of immune responses, and the broader issue of global accessibility. Finally, we review potential strategies for advancing next-generation mRNA vaccines, with the aim of overcoming current limitations in vaccine technology and enhancing both preventive and therapeutic approaches for infectious and oncological diseases.

Schlagwörter

Stichwörter der Autor:innen

cancer immunotherapyinfectious diseasesmRNA vaccinesvaccine delivery systemsvaccine development

Autor:innen und Institutionen

  • Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
  • Department of Bacteriology and Virology, Semnan University of Medical Sciences, Semnan, Iran.
  • Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran.
  • Department of Therapy and Family Medicine, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
  • Department of Medical Rehabilitation, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
  • Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.

Zitieren

APA

Haghmorad, D., Eslami, M., Orooji, N., Halabitska, I., Kamyshna, I., Kamyshnyi, O., & Oksenych, V. (2025). mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy. Frontiers in Bioengineering and Biotechnology, 13. https://doi.org/10.3389/fbioe.2025.1547025

Vancouver

Haghmorad D, Eslami M, Orooji N, Halabitska I, Kamyshna I, Kamyshnyi O, et al. mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy. Frontiers in Bioengineering and Biotechnology. 2025;13. doi:10.3389/fbioe.2025.1547025

BibTeX
@article{Haghmorad2025,
  author = {Haghmorad, Dariush and Eslami, Majid and Orooji, Niloufar and Halabitska, Iryna and Kamyshna, Iryna and Kamyshnyi, Oleksandr and Oksenych, Valentyn},
  title = {mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fbioe.2025.1547025}
}
Kostenlos starten →